XTractor Premium http:www'xtractor'inpremium - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

XTractor Premium http:www'xtractor'inpremium

Description:

Case Study 3. Pathology and Mechanism of Dengue Virus Infections. Contact us: 91 80-41205016 ... Pathology. XTractor Facts: Tryptophan Metabolism and IDO: ... – PowerPoint PPT presentation

Number of Views:46
Avg rating:3.0/5.0
Slides: 10
Provided by: xtra4
Category:

less

Transcript and Presenter's Notes

Title: XTractor Premium http:www'xtractor'inpremium


1
XTractor Premium
http//www.xtractor.in/premium
  • A platform for discovery, analysis and modelling
    of published biomedical facts-updated with
    manually annotated scientific information from
    Pubmed every single day

A Product of Molecular Connections,
INDIA www.molecularconnections.com
www.xtractor.in/premium
2
Case Study 3 Pathology and Mechanism of Dengue
Virus Infections
Contact us 91 80-41205016 xtractorpremium_at_molecu
larconnectioons.com
www.xtractor.in/premium
3
Viral Infection Stage
  • XTractor facts
  • Cells infected Myeloid dendritic cells
  • Dengue virus infection promotes translocation of
    High Mobility Group Box 1 protein from the
    nucleus to the cytosol in dendritic cells,
    upregulates cytokine production and modulates
    viral replication.
  • Additionally, the TLR7-mediated recognition of DV
    RNA may be involved in pDC functional activation.

www.xtractor.in/premium
4
Viral Infection Stage
  • XTractor facts
  • Molecules and processes involved
  • Vimentin and microtubules
  • In contrast, disruption of vimentin inhibited DV2
    infection
  • VEGF and vascular leakage
  • The experimental observation described here
    provided additional insights into potential
    mechanism for VEGF-mediated vascular leakage
    associated with DENV, and support the idea that
    there are potential applications of anti-VEGF
    therapeutic interventions for prevention of
    severe DENV infections
  • In this study, the expression level of VEGF, a
    well-established vascular permeabilizing agent
    was shown to be elevated in a time-dependent
    manner, and exhibited a unique dual-response
    profile, in a DENV-infected endothelial cell.
  • MMP2 and Vascular leakage
  • Therefore, our results demonstrated that
    endothelial cells are an important target for DV
    infection, and that DV-induced MMP-2
    overproduction by direct infection of endothelial
    cells may contribute to the pathogenesis of
    severe dengue infection.
  • CD209/ DC-SIGN
  • There is evidence that infection of immature
    myeloid dendritic cells plays a crucial role in
    dengue pathogenesis and that the interaction of
    the viral envelope E glycoprotein with
    CD209/DC-SIGN is a key element for their
    productive infection.
  • High levels of DV replication in mDC were found
    to correlate with DC-SIGN expression.

www.xtractor.in/premium
5
Viral Replication Stage
  • XTractor Facts
  • Molecules and processes involved
  • HMGB1
  • Dengue virus infection promotes translocation of
    High Mobility Group Box 1 protein from the
    nucleus to the cytosol in dendritic cells,
    upregulates cytokine production and modulates
    viral replication.
  • Chaperones Bip, Calnexin, Calreticulin
  • Knocking-down expression of BiP, calnexin, or
    calreticulin by siRNA significantly decreased the
    production of infectious dengue virions.
  • HSP60
  • RNA interference mediated silencing of Hsp60 gene
    in human monocytic myeloma cell line U937
    revealed decreased dengue virus multiplication.
  • polypyrimidine tract binding protein
  • Nevertheless, whereas PTB knockdown led to a
    significant decrease in the accumulation of DENV
    viral RNAs, it did not impair translation.

www.xtractor.in/premium
6
Pathology
  • XTractor Facts
  • Tryptophan Metabolism and IDO
  • Gene expression analysis has shown up-regulation
    of genes involved in L-tryptophan catabolism in
    models of dengue virus (DENV)-infection in vitro.
  • Our results demonstrate that IDO plays an
    important role in the antiviral effect of
    IFN-gamma against DENV infection in vitro and
    suggest a role in the immune response to DENV
    infections in vivo.
  • Hemorrhage and iNOS
  • Importantly, hemorrhage development and the
    severity of hemorrhage were greatly reduced in
    mice lacking iNOS or p47(phox) or treatment with
    oxidase inhibitor, pointing to the possibility of
    using anti-oxidant as therapeutics for dengue
    hemorrhage.
  • Inflammation and Cytokines
  • TNF and LTA Gene, Allele, and Extended HLA
    Haplotype Associations with Severe Dengue Virus
    Infection in Ethnic Thais.
  • Severe dengue virus (DENV) infection is
    characterized by a cascade of cytokine
    production, including the production of tumor
    necrosis factor-alpha (TNF-alpha) and
    lymphotoxin-alpha (LT-alpha).
  • HMGB1 regulated TNF-alpha, IL-6, IL-8 and
    IFN-alpha secretion in DENV infected DCs.

www.xtractor.in/premium
7
Potential Targets for Treatment
  • XTractor Facts
  • iNOS/NCF1 or oxidases
  • Importantly, hemorrhage development and the
    severity of hemorrhage were greatly reduced in
    mice lacking iNOS or p47(phox) or treatment with
    oxidase inhibitor, pointing to the possibility of
    using anti-oxidant as therapeutics for dengue
    hemorrhage.
  • HSP60
  • These observations suggest that, elevated levels
    of Hsp60 expression in virally infected cells may
    help in viral multiplication and could be
    possible therapeutic targets for the management
    of dengue virus infection.
  • VEGF
  • The experimental observation described here
    provided additional insights into potential
    mechanism for VEGF-mediated vascular leakage
    associated with DENV, and support the idea that
    there are potential applications of anti-VEGF
    therapeutic interventions for prevention of
    severe DENV infections.

www.xtractor.in/premium
8
  • Toxicity
  • Clearance
  • Dosing
  • Target prioritization
  • Off target effects
  • Drug reusability studies
  • Mutation/SNP analysis
  • Pathway studies
  • Disease mechanisms
  • XTractor Premium-
  • The One stop solution for all your drug discovery
    queries

For a webex/Trial access, write
to xtractorpremium_at_molecularconnections.com
www.xtractor.in/premium
9
Contact
  • For a FREE Trial access http//www.xtractor.in/tr
    ial.do
  • Or mail us at xtractorpremium_at_molecularconnection
    s.com

www.xtractor.in/premium
Write a Comment
User Comments (0)
About PowerShow.com